Gregory Guion
Psychiatric/Mental Health · Danbury, CTNPI 1154937910
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 248 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 28.9% of the total. Reporting peaked in 2022 at $1,878 and has fallen 75.4% since, to $463 in 2025. Among psychiatric/mental health clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 248 payments — averaging $25.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$731
- Neurocrine Biosciences, Inc.$702
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$701
- Axsome Therapeutics, Inc.$277
- Alkermes, Inc.$260
- plus $2K from 19 others
What the payments were for
- Food & beverage$6,32199%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$494
- INGREZZA$351
- REXULTI$350
- JORNAY PM$129
- ABILIFY MAINTENA$125
- Quillichew ER$125
- Dyanavel XR$125
- Quillivant$125
- Auvelity$125
- SPRAVATO$106
How this compares
$6,368 in reported general payments places this provider in the 95th percentile of 679 psychiatric/mental health providers in Connecticut.
See all psychiatric/mental health providers in Connecticut →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Imipramine Hcl | 11 | $1,341 |
| Gabapentin | 18 | $467 |
| Escitalopram Oxalate | 17 | $229 |
| Quetiapine Fumarate | 13 | $226 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $187 |
| Alprazolam | 20 | $45 |
| Eszopiclone | 11 | $8 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Danbury
- Donna DraperDanbury$19K
- Zahida SairitupaDanbury$19K
- Margaret ScaliaDanbury$8K
- Allison HayesDanbury$4K
- Cristina MeehanNew Britain$224K
- Samantha MrazBridgeport$87K
- Philip FrickManchester$31K
- Gia SantoroWest Haven$25K
- Hui HuNorwich$19K
- Patrick GagnonMilford$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.